Public sector
Only sustained bipartisan support and U.S. leadership can provide the strategic direction, accelerated approvals, and funding to enable our country to develop the right technologies to prevent biological events.
Private sector
Meanwhile, private organizations have the resources to provide the research, insight, manufacturing, and efficiencies needed to produce biodefense tools and innovations.